Bruton tyrosine kinase (BTK) inhibitors have become a mainstay of treatment for relapsed or refractory (R/R) mantle cell ...
Lilly opens early access to retatrutide for some patients before FDA approval, following scrutiny over a single earlier compassionate-use case. A source familiar with Lilly's program told STAT that ...
Prior authorization, coverage limits, and affordability screening increasingly determine when CAR T or bispecifics are ...
Rising summer temperatures and prolonged UV exposure can accelerate the breakdown of larger plastics into these microscopic particles, increasing opportunities for human exposure, ...
UPMC and Birth Root Community Doula describe a 4-year partnership addressing food insecurity, housing, and maternal health ...
Six peptides received narrow advisory support for potential 503A Bulks List inclusion, an atypical outcome given FDA staff recommendations against all seven under review. Legal compounding remains ...
Indication expansion enables PSMA-targeted radioligand therapy earlier in metastatic prostate cancer, pairing Pluvicto with ARP inhibition plus ADT/orchiectomy for androgen pathway ...
Greater disease severity, pruritus-related sleep disruption, and chronicity correlated with worse anxiety/depression and health-related quality of life deficits across emotional, social, academic, and ...
Divergent product biology emerged: high-dose responses tracked with naïve/central-memory enrichment, whereas low-dose ...
A federal judge heard arguments over whether CMS unlawfully narrowed the Medicaid work requirement exemption for medically frail beneficiaries. Richard G. Stearns of the U.S. District Court for the ...
The study, “Geographical Access to Preferred Pharmacies in Medicare Part D,” published in the July 2026 issue of The American Journal of Managed Care ® (AJMC ®), analyzed pr ...
Vitiligo's clinical course splits into segmental and non-segmental presentations, each carrying a distinct prognosis. Dr. Rosmarin explains how disease activity, not just extent, determines whether a ...